← Back to catalogue
Angiographic Syringes
EUDAMEDClass IIa (EU MDR)
Ref 42.16.30002 Ref 42.16.10000,42.16.10001,42,16.10002,42.16.10003,42.16.10004,42.16.10005,42.16.10007,42.16.10008,42.16.10009
Identity
- Device Name
- Angiographic Syringes EUDAMEDAngiograhpic Syringes EUDAMED
- Model / Reference
- 42.16.30002 EUDAMED42.16.10000,42.16.10001,42,16.10002,42.16.10003,42.16.10004,42.16.10005,42.16.10007,42.16.10008,42.16.10009 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 06938820515333 EUDAMED
- Basic UDI-DI
- B-06938820515333 EUDAMED69388205000000000000001ZL EUDAMED
- EMDN Code
- Z11039013 ANGIOGRAPHIC INJECTORS EUDAMED
Classification
- Device Class
- Class IIa EUDAMED
- Market of Registration
- France EUDAMED
Clinical & Handling
Sterile
Yes
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Angiographic Syringes by SCW Medicath Ltd. — Class IIa — MDR, MDD — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
European Union Active
CE/MDD
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | B-06938820515333 | Class IIa | Active |
| EUDAMED | European Union | CE/MDD | B-06938820515333 | Class IIa | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- SCW Medicath Ltd.
- EUDAMED SRN
- CN-MF-000019140
- Authorised Representative
- Obelis s.a. BE-AR-000000106
Sources (3)
- EUDAMED f49f19ab-196e-4e23-a180-8f148af1b880 61 fields · synced Jul 9, 2026
- EUDAMED c70cc964-9a20-4d10-b9fa-063fc92c66d2 61 fields · synced May 18, 2026
- EUDAMED c70cc964-9a20-4d10-b9fa-063fc92c66d2-1 61 fields · synced Jun 9, 2026